Cohen Veterans Bioscience Open House at ISTSS

Cohen Veterans Bioscience attended the International Society for Traumatic Stress Studies (ISTSS) conference in New Orleans from November 4-7, 2015.

This meeting convened leading researchers in Post-Traumatic Stress Disorder (PTSD) and related conditions, such as suicidality and traumatic brain injury, and serves as a forum for investigators to present recent breakthroughs in the understand of PTSD and trauma-related disorders.

Cohen Veterans Bioscience held an Open House to meet investigatorsat the conference and to introduce its mission and its focus on translational research. This Open House was an opportunity for experts in trauma research to discuss:

  1. Factors that will drive the field of PTSD and trauma-related research forward
  2. Tools required for new innovations

At the Open House, Magali Haas, MD, PhD, CEO and President of Cohen Veterans Bioscience outlined the mission and goals of the organization to accelerate the discovery and development of new diagnostics, therapeutics and cures for PTSD and TBI. Dr. Haas also shared feedback from an online survey completed by investigators in advance of the Open House. There is significant enthusiasm for the establishment of a non-profit research organization that can help drive public-private partnerships for these conditions.

Learn more about the International Society for Traumatic Stress Studies (ISTSS) here.

Share this article:

More from CVB

Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder

New meta-analysis builds upon PTSD genetics research, providing a foundation for the development of precision therapies

Driving Progress: TBI Action Alliance Launches Multi-Pronged Initiative to Speed Development of Diagnostic and Therapeutic Solutions for Traumatic Brain Injury

About Cohen Veterans Bioscience (CVB)

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.